febrile%20neutropenia
FEBRILE NEUTROPENIA
Febrile neutropenia is having a fever of ≥38.3 ºC or ≥38 ºC over an hour and neutropenia that is having an absolute neutrophil count (ANC) of <500 neutrophils/mm3 or an ANC <1000 neutrophils/mm3 expected to decline to ≤500 neutrophils/mm3 over the next 48 hours.
The risk of febrile neutropenia is directly proportional to the duration and severity of neutropenia.
Fever is frequently the only indication of infection in the neutropenic patient.
Drug Information

Indication: Tab & inj Short-term treatment of upper & lower resp tract, skin & soft tissue, bone & joint, ...

Indication: Upper & lower resp tract, skin & soft tissue, GUT, bone & joint infections.

Indication: Invasive aspergillosis; fluconazole-resistant serious invasive Candida infections (eg, C krusei); serious...

Indication: Nosocomial & community-acquired pneumonia including concurrent bacteremia, complicated & uncomplicated...

Indication: For adult & childn ≥12 mth: Empirical therapy for presumed fungal infections in febrile, neutropenic pa...

Indication: Cryptococcosis eg, cryptococcal meningitis & cryptococcal infections at other sites; maintenance therapy t...

Dosage: Cap Gynaecological: Vulvovag candidiasis 200 mg bd for 1 day or 200 mg once daily for 3 days. Dermatological/O

Indication: Lower resp tract, complicated & uncomplicated UTI, intra-abdominal, skin & skin structure infections; ...

Indication: Treatment of polymicrobic & mixed aerobic/anaerobic infections. Initial therapy prior to the identificatio...

Indication: Infections due to gm -ve & +ve organisms & non-penicillinase-producing staph.

1  /  11
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
31 Oct 2017
In patients with underlying heart failure (HF) or chronic obstructive pulmonary disease (COPD), concurrent episodes of community-acquired pneumonia increase the risk of disease exacerbations, such as short-term cardiac complications and respiratory failure, a recent study has shown.
16 Mar 2017
Probiotics have a long history of use in humans. Defined as "live organisms that confer a health benefit on the host when administered in adequate amounts", the spectrum of use of probiotics in humans ranges from foods and dietary supplements to pharmaceutical/nutraceutical products to affect general health and disease. While the genera Lactobacillus and Bifidobacterium are the two most common probiotics associated with consumer products, there exist other organisms (eg, the yeast Saccharomyces cerevisiae, some non-pathogenic strains of Escherichia coli and Bacillus species) that are used as probiotics.1–3 One of them is the probiotic strain B. clausii that has been found to be effective for the treatment of diarrhoea and antibiotic-associated gastrointestinal side effects.4–6
02 Nov 2017
Passive immunization with neutralizing antibodies (nAbs) do not appear to prevent transmission of HIV-1 to the infant from the infected mother’s breastmilk, a recent study suggests.